Amneal Pharmaceuticals (AMRX) News Today $9.36 -0.02 (-0.21%) Closing price 04:00 PM EasternExtended Trading$9.37 +0.01 (+0.12%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Amneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells $60,230.00 in Stock1 hour ago | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) EVP Sells $1,105,992.72 in Stock2 hours ago | marketbeat.comVirtus Advisers LLC Takes Position in Amneal Pharmaceuticals, Inc. $AMRXAugust 27 at 8:25 AM | marketbeat.comInsider Selling: AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) EVP Sells 6,340 Shares of StockAugust 26 at 5:07 AM | insidertrades.comCharles Schwab Investment Management Inc. Increases Stake in AMNEAL PHARMACEUTICALS, INC. $AMRXAugust 26 at 3:05 AM | marketbeat.comBlackBarn Capital Partners LP Boosts Stock Position in Amneal Pharmaceuticals, Inc. $AMRXAugust 25 at 7:55 AM | marketbeat.comRussell Investments Group Ltd. Raises Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRXAugust 25 at 3:42 AM | marketbeat.comInvesco Ltd. Buys 365,467 Shares of Amneal Pharmaceuticals, Inc. $AMRXAugust 24 at 3:30 AM | marketbeat.comAmneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Vanguard Group Inc.August 24 at 3:17 AM | marketbeat.comAndrew Boyer Sells 279,244 Shares of Amneal Pharmaceuticals (NASDAQ:AMRX) StockAugust 23, 2025 | insidertrades.comEntryPoint Capital LLC Invests $423,000 in Amneal Pharmaceuticals, Inc. $AMRXAugust 23, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. $AMRX Stock Holdings Lifted by Quantbot Technologies LPAugust 23, 2025 | marketbeat.comNuveen LLC Invests $19.58 Million in Amneal Pharmaceuticals, Inc. $AMRXAugust 22, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. $AMRX Shares Bought by Deutsche Bank AGAugust 22, 2025 | marketbeat.comAlgert Global LLC Grows Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRXAugust 21, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Rating of "Buy" by AnalystsAugust 21, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) EVP Sells $666,037.26 in StockAugust 17, 2025 | marketbeat.comAMNEAL PHARMACEUTICALS (NASDAQ:AMRX) Reaches New 12-Month High - Here's What HappenedAugust 17, 2025 | marketbeat.comAMNEAL PHARMACEUTICALS (NASDAQ:AMRX) Sets New 52-Week High - Time to Buy?August 17, 2025 | americanbankingnews.comNikita Shah Sells 71,694 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) StockAugust 16, 2025 | insidertrades.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) EVP Sells $199,100.00 in StockAugust 15, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) EVP Sells $302,595.80 in StockAugust 15, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) EVP Sells $452,000.00 in StockAugust 15, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Connor Clark & Lunn Investment Management Ltd.August 15, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) EVP Sells $199,100.00 in StockAugust 14, 2025 | insidertrades.comAvantor, Viatris, and Amneal Stocks Trade Up, What You Need To KnowAugust 14, 2025 | msn.comAMRX Q2 Deep Dive: New Product Launches and Specialty Momentum Shape GuidanceAugust 14, 2025 | finance.yahoo.com1 Value Stock to Keep an Eye On and 2 Facing ChallengesAugust 11, 2025 | finance.yahoo.com1 Value Stock to Keep an Eye On and 2 Facing ChallengesAugust 11, 2025 | finance.yahoo.comEarnings Beat: Amneal Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsAugust 10, 2025 | finance.yahoo.comAmneal (AMRX) Q2 EPS Jumps 56%August 9, 2025 | theglobeandmail.comAmneal Pharmaceuticals (NASDAQ:AMRX) Issues FY 2025 Earnings GuidanceAugust 6, 2025 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Issues Quarterly Earnings ResultsAugust 6, 2025 | marketbeat.comAmneal Pharmaceuticals Inc (AMRX) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 5, 2025 | finance.yahoo.comAmneal Pharmaceuticals, Inc. (AMRX) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comAmneal Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.comAmneal Pharmaceuticals beats Q2 estimates, raises full-year outlookAugust 5, 2025 | ca.investing.comAmneal Pharmaceuticals lifts annual outlook after strong Q2, Specialty segment drives growthAugust 5, 2025 | msn.comAmneal (NASDAQ:AMRX) Misses Q2 Sales TargetsAugust 5, 2025 | msn.comKnight Therapeutics Announces Regulatory Submission of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in MexicoAugust 5, 2025 | globenewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)August 5, 2025 | marketbeat.com38,900 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Purchased by Allianz Asset Management GmbHAugust 5, 2025 | marketbeat.comAmneal Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comA Peek at Amneal Pharmaceuticals's Future EarningsAugust 5, 2025 | benzinga.comXTX Topco Ltd Buys 43,221 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)August 5, 2025 | marketbeat.comMackenzie Financial Corp Purchases 156,609 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)August 5, 2025 | marketbeat.comPhocas Financial Corp. Sells 71,035 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)August 4, 2025 | marketbeat.comAmneal Earnings: What To Look For From AMRXAugust 4, 2025 | finance.yahoo.comEmpirical Financial Services LLC d.b.a. Empirical Wealth Management Has $751,000 Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)August 3, 2025 | marketbeat.comAmneal Pharmaceuticals Secures $2.1 Billion in LoansAugust 2, 2025 | msn.com Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMRX Media Mentions By Week AMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼1.130.97▲Average Medical News Sentiment AMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼186▲AMRX Articles Average Week Get the Latest News and Ratings for AMRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ASND News Today QGEN News Today MRNA News Today BBIO News Today ELAN News Today VRNA News Today ROIV News Today GRFS News Today RVMD News Today RYTM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access